Analyst Price Target is $9.25
▲ +444.12% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Allurion Technologies in the last 3 months. The average price target is $9.25, with a high forecast of $16.00 and a low forecast of $2.50. The average price target represents a 444.12% upside from the last price of $1.70.
Current Consensus is
Hold
The current consensus among 4 contributing investment analysts is to hold stock in Allurion Technologies. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Read More